Facial Injectors Market

Facial injectors are drugs used for facial rejuvenation, treating scars, lip augmentation, for the correction of perioral rhytids, cheek augmentation, and other facial improvements. The growing demand for facial aesthetic treatments and technological advancements has led to the growth of the facial injectors market in recent years. Factors such as adverse effects of pollution on the face and increasing acceptance of soft tissue fillers contribute to the growth of the market. In addition to this, the increasing demand for dermal filler techniques in the Asian region is expected to fuel the growth of the market. However, complications during surgeries, the black market, and side-effects connected with facial injectors are likely to restrain the market growth over the forecast period.

The global facial injectors market is growing at a rapid pace. The global facial injectors market is expected to reach USD 14571.47 million by 2023 from USD 7740.16 million in 2017 and is expected to register a CAGR of 11.12% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 44.0% share, followed by Europe and Asia-Pacific with shares of 32% and 17.8%, respectively.

The market has been segmented based on type, application, and end-user.

The global facial injectors market on the basis of type has been segmented into dermal fillers/injector implants and anti-aging/anti-wrinkle injections. On the basis of type, dermal fillers/injector implants accounted for the largest market share of 53% in 2017, with a market value of USD 4104.84 million, which is projected to register a CAGR of 11.61% during the forecast period. The anti-aging/anti-wrinkle injections segment accounted for a market share of 47% in 2017, with a market value of USD 3635.32 million, which is projected to register a CAGR of 10.55% during the forecast period.

The global facial injectors market on the basis of application has been segmented into facial line correction treatment, face-lift, and lip treatments. On the basis of application, the facial line correction treatment accounted for the largest market share of 45.5% in 2017, with a market value of USD 3519.13 million, which is projected to register a CAGR of 10.43% during the forecast period. The face-lift segment accounted for a market share of 36.5% in 2017, with a market value of USD 2824.16 million, which is projected to register a CAGR of 11.84% during the forecast period. The lip treatments segment accounted for a market share of 12.1% in 2017, with a market value of USD 939.68 million, which is projected to register a CAGR of 11.40% during the forecast period. Other segments accounted for a market share of 5.9% in 2017, with a market value of USD 457.18 million.

The market based on end-user has been segmented into dermatology clinics and cosmetic centers, hospitals, and others. Based on end-user, dermatology clinics and cosmetic centers accounted for the largest market share of 42.4% in 2017, with a market value of USD 3279.65 million, which is projected to register a CAGR of 10.78% over the assessment period. The hospitals segment accounted for a market share of 39.1% in 2017, with a market value of USD 3026.78 million, which is projected to register a CAGR of 11.45% over the assessment period. Other segments accounted for a market share of 18.5% in 2017, with a market value of USD 1433.72 million.